Literature DB >> 1384663

Quantitative acute leukemia cytogenetics.

F Mitelman1, S Heim.   

Abstract

Using literature data on cytogenetic abnormalities in 3,612 cases of acute myeloid leukemia (AML) and 1,551-cases of acute lymphocytic leukemia (ALL), we have attempted to quantify the information value of finding the typical ALL- and AML-associated chromosome aberrations. Sensitivity, specificity, and predictive value of finding or not finding a given aberration were calculated for several diagnostic scenarios: for the differential diagnosis between ALL and AML when the patient is known to have acute leukemia, for the differential diagnosis among AML FAB subtypes in a patient with known AML, and for the differential diagnosis between ALL FAB subtypes in a patient with known ALL. The specificities were generally high, close to 1. The highest sensitivities in AML were found for +8, t(15;17)(q22;q11), t(8;21)(q22;q22), and -7 (all greater than 0.1), and in ALL for t(9;22)(q34;q11), t(4;11)(q21;q23), and +21 (again all greater than 0.1). In the AML subtypes, the highest sensitivities were 0.89 for t(15;17)(q22;q11) in M3, followed by 0.40 for t(8;21)(q22;q22) in M2, 0.30 for inv(16)(p13q22)/del(16)(q22)/t(16;16)(p13;q22) in M4, and 0.16 for t(9;11)(p21;q23) in M5. In the ALL subtypes, the highest sensitivities were 0.71 and 0.11 for t(8;14)(q24;q32) and t(8;22)(q24;q11), respectively, in L3, 0.23 for t(9;22)(q34;q11) in L2, and 0.18 and 0.13 for +21 and t(4;11)(q21;q23), respectively, in L1. The highest (1.0) positive predictive values in the AML versus ALL comparison were found for t(1;3)(p36;q21), inv(3)(q21q26), t(6;9)(p23;q34), t(7;11)(p15;p15), t(8;16)(p11;p13), t(8;21)(q22;q22), t(15;17)(q22;q11), and, as sole anomalies, for +4, +9, and +11. In the reverse comparison, ALL versus AML, positive predictive values of 1.0 were found for t(1;14)(p32-34;q11), dup(I)(q12-21q31-32), t(2;8)(p12;q24), t(8;14)(q24;q32), t/dic(9;12)(p11-12;p11-13), t(10;14)(q24;q11), and t(11;14)(p13;q11). Among the AML subgroups, the highest predictive values were: 1.0 for M3 if t(15;17), 0.91 for M2 if t(8;21), 0.86 for M4 if inv/del(16)/t(16;16), and 0.82 for M5 if t(9;11). Among the ALL subtypes, positive predictive values of greater than 0.8 were reached only for the L3-associated aberrations t(2;8) (1.0), t(8;14) (0.95), t(8;22) (0.87), and dup(I) (0.80). The highest negative predictive values were in AML 0.98 that the disease is not M3 if t(15;17) is not found, and in ALL 0.96 that the patient does not have L3 if a t(8;14) is not detected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384663     DOI: 10.1002/gcc.2870050109

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Acute myeloid leukemia (FAB-M2) with a masked type of t(8;21) translocation revealed by spectral karyotyping.

Authors:  Jun-ichi Miyagi; Naoki Kakazu; Masato Masuda; Takashi Miyagi; Tamiko Toyohama; Tetsuro Nakazato; Takeaki Tomoyose; Tetsuharu Shinjyo; Akitoshi Nagasaki; Naoya Taira; Misao Ohki; Tatsuo Abe; Nobuyuki Takasu
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Ten-year experiences on initial genetic examination in childhood acute lymphoblastic leukaemia in Hungary (1993-2002). Technical approaches and clinical implementation.

Authors:  Eva Olah; Erzsebet Balogh; Laszlo Pajor; Zsuzsanna Jakab
Journal:  Pathol Oncol Res       Date:  2010-06-24       Impact factor: 3.201

3.  Chromosomal location of the Syk and ZAP-70 tyrosine kinase genes in mice and humans.

Authors:  G Ku; B Malissen; M G Mattei
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  A chromosome study on 97 cases of acute nonlymphocytic leukemia M2.

Authors:  F J Chen; A D Yang; H B Fei
Journal:  J Tongji Med Univ       Date:  1994

Review 5.  Leukemogenesis of the EVI1/MEL1 gene family.

Authors:  Kazuhiro Morishita
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

6.  Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21.

Authors:  A Orr-Urtreger; L Trakhtenbrot; R Ben-Levy; D Wen; G Rechavi; P Lonai; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.

Authors:  C Sakakura; Y Yamaguchi-Iwai; M Satake; S C Bae; A Takahashi; E Ogawa; A Hagiwara; T Takahashi; A Murakami; K Makino
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 8.  The robotic mouse: understanding the role of AF4, a cofactor of transcriptional elongation and chromatin remodelling, in purkinje cell function.

Authors:  Emmanuelle Bitoun; Kay E Davies
Journal:  Cerebellum       Date:  2009-04-02       Impact factor: 3.847

9.  Subtype-specific patterns of molecular mutations in acute myeloid leukemia.

Authors:  D Rose; T Haferlach; S Schnittger; K Perglerová; W Kern; C Haferlach
Journal:  Leukemia       Date:  2016-06-10       Impact factor: 11.528

Review 10.  HDAC8 substrates: Histones and beyond.

Authors:  Noah A Wolfson; Carol Ann Pitcairn; Carol A Fierke
Journal:  Biopolymers       Date:  2013-02       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.